| Page 1520 | Kisaco Research
 

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras
 

Francisco Jardim

Co-Founder and Managing Director
SP Ventures

Francisco Jardim

Co-Founder and Managing Director
SP Ventures

Francisco Jardim

Co-Founder and Managing Director
SP Ventures
 

Marcelo Ceccim

Advisor
CowMed

Marcelo Ceccim

Advisor
CowMed

Marcelo Ceccim

Advisor
CowMed
 

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures
 

Cristina Jorge

Director
CMJ Consultoria & Assessoria

Cristina Jorge

Director
CMJ Consultoria & Assessoria

Cristina Jorge

Director
CMJ Consultoria & Assessoria
 

Ricardo Negri

Professor
ITBA

Ricardo Negri

Professor
ITBA

Ricardo Negri

Professor
ITBA
 

Josue Caride

CEO & Co-Founder
Sampp.co

Josue Caride

CEO & Co-Founder
Sampp.co

Josue Caride

CEO & Co-Founder
Sampp.co
 

Daniel Hato

Owner
Dr Hato Veterinary Hospital

Daniel Hato

Owner
Dr Hato Veterinary Hospital

Daniel Hato

Owner
Dr Hato Veterinary Hospital
 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

 

Alex Mira (VIRTUAL)

Senior Researcher
Fundación FISABIO

Alex Mira obtained an honour distinction for his BSc in Biology at the University of Alicante, Spain, in 1994. He then obtained a British Council scholarship to do a Master of Science degree at Oxford University (UK) and was the first Spanish student to be awarded a Rhodes scholarship, which allowed him to do his doctorate at Oxford on bacterial genetics, which he finished in 1999.

Alex Mira (VIRTUAL)

Senior Researcher
Fundación FISABIO

Alex Mira (VIRTUAL)

Senior Researcher
Fundación FISABIO

Alex Mira obtained an honour distinction for his BSc in Biology at the University of Alicante, Spain, in 1994. He then obtained a British Council scholarship to do a Master of Science degree at Oxford University (UK) and was the first Spanish student to be awarded a Rhodes scholarship, which allowed him to do his doctorate at Oxford on bacterial genetics, which he finished in 1999.

He then was awarded a Fulbright scholarship to carry out post-doctoral research in the USA in the field of bacterial genomics for 2 and a half years, and a second post-doc at Uppsala University (Sweden) working on microarray technology and bioinformatics.

After 9 years abroad, he returned to Spain with the Ramón y Cajal repatriation program in 2003 and initiated his own research group working on the genomics and metagenomics of oral bacteria.

In 2009, he was awarded the “Jaime Ferran” National Award for Research in Microbiology and he is currently the principal investigator of the Oral Microbiome Laboratory at the CSISP, in Spain, where he has applied metagenomics and next-generation sequencing technology to the study of dental caries, discovering the presence of bacteria which prevent the formation of cavities, as well as to the study of bacteria from breast milk, saliva, and the respiratory tract.